Altered Gut Microbiome in Parkinson’s Disease and the Influence of Lipopolysaccharide in a Human α-Synuclein Over-Expressing Mouse Model
The interaction between the gut microbiota and alpha-synuclein (αSyn) aggregation in Parkinson’s disease (PD) is receiving increasing attention. The objective of this study was to investigate gut microbiota, and effects of an inflammatory lipopolysaccharide (LPS) trigger in a human αSyn over-express...
Main Authors: | Anastazja M. Gorecki, Leah Preskey, Megan C. Bakeberg, Jade E. Kenna, Christi Gildenhuys, Gabriella MacDougall, Sarah A. Dunlop, Frank L. Mastaglia, P. Anthony Akkari, Frank Koengten, Ryan S. Anderton |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-08-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnins.2019.00839/full |
Similar Items
-
Single Nucleotide Polymorphisms Associated With Gut Homeostasis Influence Risk and Age-at-Onset of Parkinson's Disease
by: Anastazja M. Gorecki, et al.
Published: (2020-11-01) -
Changes in the Gut Microbiome and Predicted Functional Metabolic Effects in an Australian Parkinson’s Disease Cohort
by: Jade E. Kenna, et al.
Published: (2021-10-01) -
TOMM40 ‘523’ poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson’s disease
by: Megan C. Bakeberg, et al.
Published: (2021-07-01) -
The TOMM40 ‘523’ polymorphism in disease risk and age of symptom onset in two independent cohorts of Parkinson’s disease
by: Megan C. Bakeberg, et al.
Published: (2021-03-01) -
Elevated HDL Levels Linked to Poorer Cognitive Ability in Females With Parkinson’s Disease
by: Megan C. Bakeberg, et al.
Published: (2021-06-01)